AFP and hepatocellular carcinoma: Scientists use AFP-L3 to separate AFP elevations that result from HCC from those that originate from benign liver disease.[22] The AFP-L3 isoform achieves higher diagnostic specificity for HCC since it measures against the total AFP concentration.[23]